Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. Mar 15, 2023; 15(3): 546-561
Published online Mar 15, 2023. doi: 10.4251/wjgo.v15.i3.546
Figure 7
Figure 7 Estimated IC50 of different chemotherapy drugs between the high- and low-risk groups. A: Oxaliplatin; B: 5-Fluorouracil; C: Irinotecan; D: Cisplatin; E: Wnt_C59; F: KRAS_Inhibitor; G: Gefitinib; H: Erlotinib; I: Nilotinib; J: Afatinib; K: ABT737; L: Paclitaxel. aP < 0.05; bP < 0.01; cP < 0.001.